301290.SHE Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A
- Market cap
- CNY 2.56B
- P/E
- -
- P/B
- 1.17x
- ROE
- 3.2%
- Dividend yield
- 2.36%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 301290.SHE undervalued?
Graham numberThe Graham number of Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A fundamental analysis
No fundamental analysis for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A yet.
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A
Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. engages in the research, development, manufacturing, and sale of surgical medical devices, staplers, and spare parts in China. It offers orthopedic traction frames, surgical lamps, hospital system integration solutions, electric gynecological examination tables, obstetrics and gynecology examination tables, electric operating tables, multi-functional intelligent operating tables, ventilators, surgical endoscopes, ultrasound …
Full company profileJiangsu Canopus Wisdom Medical Technology Co. Ltd. A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 374M | 446M | 442M | 434M | 435M | 387M | 361M |
| Gross Profit | 208M | 256M | 231M | 209M | 215M | 188M | 175M |
| Operating Income | 97.4M | 129M | 115M | 88.5M | 84.6M | 54.1M | 44.6M |
| EBITDA | - | - | 156M | 156M | 158M | 15.7M | 82.9M |
| Net Income | 79.7M | 110M | 103M | 97.2M | 97.4M | -37.9M | 68.3M |
| EPS | 1.06 | 1.47 | 1.02 | 0.97 | 0.97 | -0.38 | 0.68 |
| Balance Sheet | |||||||
| Total Assets | 1.14B | 1.24B | 2.38B | 2.39B | 2.48B | 2.43B | 2.38B |
| Total Liabilities | 157M | 147M | 180M | 147M | 229M | 274M | 222M |
| Shareholders' Equity | 976M | 1.09B | 2.19B | 2.24B | 2.25B | 2.15B | 2.15B |
| Cash & Short-term Investments | 122M | 138M | 1.11B | 569M | 295M | 78.4M | 192M |
| Cash Flow | |||||||
| Operating Cash Flow | 114M | 163M | 94.6M | 163M | 126M | 84.1M | - |
| Capital Expenditure | 25.4M | 95.7M | 74.4M | 111M | 116M | 46.1M | 81.9M |
| Free Cash Flow | 88.6M | 67.8M | 20.3M | 51.7M | 10.5M | 38.0M | -8.47M |
| Ratios | |||||||
| ROE | 8.2% | 10.2% | 4.7% | 4.3% | 4.3% | -1.8% | 3.2% |
| ROA | 7.0% | 8.9% | 4.3% | 4.1% | 3.9% | -1.6% | 2.9% |
| Net Profit Margin | 21.3% | 24.7% | 23.2% | 22.4% | 22.4% | -9.8% | 18.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A dividends
- Dividend yield
- 2.36%
- Forward dividend
- 0.30 CNY
- Payout ratio
- -
- Ex-dividend date
- Jun 10, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 60.4M | 0.60 | - |
| 2024 | CNY 59.6M | 0.59 | 61.2% |
| 2023 | CNY 50.1M | 0.50 | 51.5% |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | CNY 2.30M | 0.03 | 2.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A
- Insiders 45.23%
- Institutions 2.76%
- Public & others 52.02%
- Shares outstanding 100M
- Free float 58.3M
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A company profile
- Company name
- Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A
- Ticker
- 301290.SHE
- ISIN
- CNE1000065F2
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 727
- Fiscal year end
- December
- Address
- No. 24-4, Changyang Road, Changzhou, China, 213115
- Phone
- 86 519 8668 7028
- Website
- dx-med.com
About Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A
Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. engages in the research, development, manufacturing, and sale of surgical medical devices, staplers, and spare parts in China. It offers orthopedic traction frames, surgical lamps, hospital system integration solutions, electric gynecological examination tables, obstetrics and gynecology examination tables, electric operating tables, multi-functional intelligent operating tables, ventilators, surgical endoscopes, ultrasound equipment, hydrogen peroxide low-temperature plasma sterilizers, and multifunctional monitoring modules; medical consumables; and open stapler surgical equipment, such as linear cutting stapler, tubular stapler, and hemorrhoidal stapler. The company also provides surgical equipment, such as monitor stands, endoscope compound arm pendant, compound arm crane, dry and wet separation suspension bridges, hanging columns, electric endoscope pendant, cavity mirror hanging towers, cavity mirror pendant towers, and electric delivery beds. It also exports its products to Europe, South America, Southeast Asia, the Middle East, and Africa. The company was founded in 2001 and is based in Changzhou, China.
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A management
4- Mr. Jiangang WeiGM & Director · born 1972
- Ms. Aiqing GongCFO, Deputy GM, Board Secretary & Director · born 1971
- Mr. Zhengyuan WanDeputy GM & Director · born 1988
- Xu HailanAccounting Supervisor